Wow, if that is true, it's appalling. They can't use some of the funds from selling shares to move the ball a little bit on eczema studies? We're 1/3 through Q3 already. At least the GB trials are listed at clinical trials.gov, for whatever that is worth.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.